1. Home
  2. CIM vs WVE Comparison

CIM vs WVE Comparison

Compare CIM & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIM
  • WVE
  • Stock Information
  • Founded
  • CIM 2007
  • WVE 2012
  • Country
  • CIM United States
  • WVE Singapore
  • Employees
  • CIM N/A
  • WVE N/A
  • Industry
  • CIM Real Estate Investment Trusts
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIM Real Estate
  • WVE Health Care
  • Exchange
  • CIM Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CIM 965.2M
  • WVE 939.3M
  • IPO Year
  • CIM 2007
  • WVE 2015
  • Fundamental
  • Price
  • CIM $12.61
  • WVE $6.52
  • Analyst Decision
  • CIM Hold
  • WVE Strong Buy
  • Analyst Count
  • CIM 2
  • WVE 11
  • Target Price
  • CIM $16.00
  • WVE $20.91
  • AVG Volume (30 Days)
  • CIM 533.6K
  • WVE 1.7M
  • Earning Date
  • CIM 05-08-2025
  • WVE 05-08-2025
  • Dividend Yield
  • CIM 11.56%
  • WVE N/A
  • EPS Growth
  • CIM N/A
  • WVE N/A
  • EPS
  • CIM 1.52
  • WVE N/A
  • Revenue
  • CIM $326,755,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • CIM $11.59
  • WVE N/A
  • Revenue Next Year
  • CIM $2.13
  • WVE N/A
  • P/E Ratio
  • CIM $8.43
  • WVE N/A
  • Revenue Growth
  • CIM 11.90
  • WVE N/A
  • 52 Week Low
  • CIM $9.85
  • WVE $4.25
  • 52 Week High
  • CIM $16.89
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CIM 56.82
  • WVE 43.25
  • Support Level
  • CIM $11.96
  • WVE $5.62
  • Resistance Level
  • CIM $13.28
  • WVE $6.73
  • Average True Range (ATR)
  • CIM 0.34
  • WVE 0.60
  • MACD
  • CIM 0.16
  • WVE 0.07
  • Stochastic Oscillator
  • CIM 67.13
  • WVE 36.10

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: